Clearside Biomedical, Inc. (CLSD) Buy Target $2.26 Sell Target $2.97

Trade Setup

Buy Target $2.26
Sell Target $2.97

Clearside Biomedical, Inc., a late-stage clinical biopharmaceutical company, develops pharmacological therapies to restore and preserve vision for people with serious eye diseases. It develops XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of macular edema associated with uveitis, diabetic macular edema, and macular edema associated with retinal vein occlusion.

 
Trending Ideas

Featured Stocks On The Move

Featured Stocks On The Move